Loading...

Global Secular Trends Will Drive Adoption Of Targeted Oncology Therapies

Published
13 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-57.0%
7D
4.3%

Author's Valuation

US$66.2591.6% undervalued intrinsic discount

AnalystHighTarget Fair Value